Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-3)

Sponsor
Heidelberg Engineering GmbH (Industry)
Overall Status
Recruiting
CT.gov ID
NCT02785042
Collaborator
(none)
249
8
1
83
31.1
0.4

Study Details

Study Description

Brief Summary

This prospective, single-arm clinical multicenter study intends to measure normal structural parameters of the optic nerve head, the peripapillary retinal nerve fiber layer, and the macula using the Heidelberg Spectralis OCT device. This study is conducted in Hispanic descent volunteers. The main goal of the study is to provide the range of these structural parameters in normal eyes. The study will include at least 240 normal volunteers.

Condition or Disease Intervention/Treatment Phase
  • Device: Heidelberg Spectralis OCT
N/A

Detailed Description

This prospective, single-arm clinical multicenter study intends to measure normal structural parameters of the optic nerve head, the peripapillary retinal nerve fiber layer, and the macula using the Heidelberg Spectralis OCT device. This study is conducted in Hispanic descent volunteers. The main goal of the study is to provide the range of these structural parameters in normal eyes. The study will include at least 240 normal volunteers; up to 10 study sites will recruit subjects. Overall an approximately equal age distribution from 18 to 90 years and an approximately equal number of females and males will be enrolled (approximately 40-60% females in each age group). All subjects will undergo Spectralis OCT imaging, biometric and ophthalmoscopic examination, disc photography and visual field testing in one single visit, if possible. Repeated perimetry or Spectralis scans may be performed at a second visit within 30 days of the initial visit. All examinations performed on the subjects are non-significant risk procedures.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
249 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-3)
Actual Study Start Date :
Jun 1, 2016
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
May 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Normal healthy volunteers

imaging with Heidelberg Spectralis OCT

Device: Heidelberg Spectralis OCT
OCT imaging

Outcome Measures

Primary Outcome Measures

  1. Bruch-Membrane-Opening - Minimum Rim Width (µm) [Baseline]

    Bruch-Membrane-Opening - Minimum Rim Width (µm)

  2. Bruch-Membrane-Opening - Minimum Rim Area (µm^2) [Baseline]

    Bruch-Membrane-Opening - Minimum Rim Area (µm^2)

  3. Peripapillary Retinal Nerve Fibre Layer Thickness (µm) [Baseline]

    Peripapillary Retinal Nerve Fibre Layer Thickness (µm)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Able and willing to undergo the test procedures, give consent, and to follow instructions.

  • Signed informed consent

  • Age ≥18 to 90.

  • Healthy eye without prior intraocular surgery (except cataract surgery and Laser in Situ Keratomileusis) and without clinically significant vitreal, retinal or choroidal diseases, clinically significant diabetic retinopathy (subject may have diabetes), or disease of the optic nerve. Small drusen are acceptable in older subjects.

  • Hispanic decent (self-reported)

  • Negative history of glaucoma (not including family history)

  • Intraocular pressure ≤21mmHg.

  • Best corrected visual acuity ≥20/40.

  • Refraction between +6 and -6 diopters and astigmatism ≤ 2 diopters.

  • Axial length ≤ 26.0 mm (by optical biometry)

  • Normal visual field with Glaucoma Hemifield Test and Mean Deviation within normal limits or not abnormal visual field by judgment of the ophthalmologist / optometrist

  • Clinically normal appearance of the optic disc, with normal appearing neuroretinal rim with respect to color and shape. The optic disc is examined ophthalmoscopically and by evaluation of stereo photographs.

  • If both eyes are eligible, both eyes enter the study.

Exclusion Criteria:
  • Vulnerable subjects (as defined in ISO 14155 GCP) with the exception of employees of the site, and, if applicable, students of the respective university. Staff that is listed on the delegation form are excluded from participation.

  • Subjects unable to read or write

  • Unreliable visual field. The reliability indices should be used as guide as well as the perimetrist's notes.

  • Unusable disc stereo photos.

  • Inability to undergo the tests.

  • Insufficient quality of Spectralis OCT images (this is not determined until after Spectralis OCT examination, and is an unusual circumstance).

Contacts and Locations

Locations

Site City State Country Postal Code
1 University California San Diego La Jolla California United States 92093
2 Assil Eye Institute Santa Monica California United States 90404
3 North Bay Eye Associates Santa Rosa California United States 95401
4 Mid Florida Eye Center Clinic Mount Dora Florida United States 32757
5 Illinois Eye Institute, Illinois College of Optometry Chicago Illinois United States 60616
6 SUNY College of Optometry New York New York United States 10036
7 Ophthalmic Consultants of Long Island-Valley Stream Valley Stream New York United States 11581
8 Wills Eye Hospital Philadelphia Pennsylvania United States 19107

Sponsors and Collaborators

  • Heidelberg Engineering GmbH

Investigators

  • Principal Investigator: Balwantray Chauhan, OD, Department of Ophthalmology and Visual Sciences Dalhousie University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Heidelberg Engineering GmbH
ClinicalTrials.gov Identifier:
NCT02785042
Other Study ID Numbers:
  • S-2015-3-hi
First Posted:
May 27, 2016
Last Update Posted:
May 5, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 5, 2022